Skip to main content

Table 1 Characteristics of studies included in the systematic review and meta-analysis of adherence to option B + ART in SSA

From: Adherence to option B + antiretroviral therapy and associated factors in pregnant and breastfeeding women in Sub-Saharan Africa: a systematic review and meta-analysis

Author

Country

Study design

Year of publication

Year of data collection

Study population (women)

N in analysis

Instrument of adherence measure

Recall time frame (in days)

Study evaluated associated factors

1

Abdisa et al. [16]

Ethiopia

Cross-sectional

2021

2019

Pregnant and breastfeeding

254

Self -Report

03

Yes

2

Abebe et al. [40]

Ethiopia

Cross-sectional

2022

2018

pregnant

368

Self-Report (Center for Adherence Support Evaluation (CASE) index)

07

Yes

3

Adeniyi et al. [22]

South Africa

Cross-sectional

2018

2016

pregnant

1592

Pharmacy refill + Self-Report

30

Yes

4

Adeniyi et al. [17]

South Africa

Cross-sectional

2020

2018

Breastfeeding

485

Self –Report

01

Yes

5

Aduloju et al. [19]

Nigeria

Cross-sectional

2020

2018–2020

Pregnant

170

Pill count + modified Morisky Medication Adherence Scale (MMAS)

30

Yes

6

Aferu et al. [41]

Ethiopia

Cross-sectional

2020

2018

Pregnant

103

Self-Report

90

Yes

7

Agboeze et al. [20]

Nigeria

Cross-sectional

2018

2016

Pregnant

268

Self –Report

03

Yes

8

Alcaide et al. [39]

South Africa

Controlled clinical trial

2017

Not reported

Pregnant

379

Dry Blood Spot (DBS)

03

No

9

Aregbesola et al. [65]

Nigeria

Cross-sectional

2018

2015

Pregnant

126

Self –Report (CASE)

Not reported

Yes

10

Asefa et al. [23]

Ethiopia

Cross-sectional

2020

2018

Pregnant and breastfeeding

180

Self -Report

03

Yes

11

Atanga et al. [42]

Cameroon

Cohort

2018

2013–2015

Pregnant and breastfeeding

185

Self –Report (questionnaire) + pharmacy refill + Self –Report (Visual Analogue Scale (VAS) tool)

30

No

12

Brittain et al. [43]

South Africa

Cross-sectional

2018

2013–2017

Pregnant

482

Self –Report

30

Yes

13

Calder et al. [44]

Nigeria

Controlled clinical trial

2020

2013–2015

Pregnant

210

Self –Report (VAS tool)

15

Yes

14

Dada et al. [14]

Nigeria

Cross-sectional

2021

Not reported

Pregnant and breastfeeding

284

Self –Report + pill count

30

Yes

15

Decker et al. [18]

Uganda

Cohort

2017

2013

Breastfeeding

42

Self –Report + pill count

30

Yes

16

Ebuy et al. [11]

Ethiopia

Cross-sectional

2014

2014

Pregnant

263

Self –Report

03

Yes

17

Erlwanger et al. [45]

Zimbabwe

Controlled clinical trial

2017

2014–2015

Pregnant and breastfeeding

1113

Medication Possession Ratio (MPR)

30

Yes

18

Fedlu et al. [25]

Ethiopia

Cross-sectional

2020

2019

Pregnant and breastfeeding

190

Self –Report + pill count

30

Yes

19

Fernandez-Luiz et al. [46]

Mozambique; south Africa; Mali

Cohort

2022

2018–2020

Pregnant

99

Self –Report

Not reported

No

20

Gebretsadik et al. [47]

Ethiopia

Cross-sectional

2020

2017

Pregnant and breastfeeding

350

Self –Report

Not reported

Yes

21

Haas et al. [48]

Malawi

Cohort

2016

2011–2013

Pregnant and breastfeeding

765

Electronic Medical Records System

90

No

22

Itoua et al. [38]

Republic of Congo

Cross-sectional

2015

2014

Pregnant and breastfeeding

130

Not reported

07

Yes

23

Kadima et al. [26]

Lesotho

Cohort

2018

2016

Pregnant

107

pill count

03

Yes

24

Larsen et al. [49]

South Africa

Cohort

2019

2012–2014

breastfeeding

1572

Self –Report

90

No

25

Matthews et al. [67]

South Africa; Uganda

Cohort

2020

2015–2017

Pregnant and breastfeeding

437

Real-time Electronic Adherence Monitor

01

No

26

Mukose et al. [24]

Uganda

Cohort

2021

2013–2016

Pregnant and breastfeeding

410

Self –Report (VAS)

30

No

27

Mukosha et al. [50]

Zambia

Cross-sectional

2020

Not reported

Pregnant

71

MPR

Not reported

Yes

28

Nsubuga-Nyombi et al. [51]

Uganda

Cross-sectional

2018

Not reported

Pregnant and breastfeeding

122

Self –Report

Not reported

Yes

29

Nutor et al. [66]

Zambia

Cross-sectional

2020

2016

Pregnant and breastfeeding

150

Self-Report

07

Yes

30

Omonaiye et al. [52]

Nigeria

Cross-sectional

2019

2018

Pregnant

275

Self –Report  (Adult AIDS Clinical Trial Groups (AACTG) standardized survey)

04

Yes

31

Omonaiye et al. [53]

Nigeria

Cross-sectional

2019

2018

Pregnant

275

Pharmacy refill

02

 

32

Onono et al. [54]

Kenya

Cross-sectional

2020

2017

breastfeeding

200

Self –Report

30

No

33

Phillips et al. [55]

South Africa

Cross-sectional

2017

2013

Pregnant and breastfeeding

452

Self –Report

30

Yes

34

Phillips et al. [56]

South Africa

Controlled clinical trial

2016

2013–2014

Pregnant and breastfeeding

517

Self –Report

30

No

35

Ramlagan et al. [57]

South Africa

Cross-sectional

2018

2014–2015

Pregnant

673

Self –Report (AACTG)

04

No

36

Ramlagan et al. [58]

South Africa

Controlled clinical trial

2019

2014–2017

Pregnant

683

Self –Report (AACTG)

04

Yes

37

Schnack et al. [59]

Uganda

Cohort

2016

Not reported

Pregnant

76

Pill count

30

No

38

Tarekegn et al. [60]

Ethiopia

Cross-sectional

2019

2017

Pregnant

293

Self –Report

03

Yes

39

Tesfaye et al. [61]

Ethiopia

Cross-sectional

2019

2017

Pregnant

290

Self –Report

03

Yes

40

Tsegaye et al. [62]

Ethiopia

Cross-sectional

2016

2016

Pregnant and breastfeeding

190

Self –Report + pill count

30

Yes

41

Wondimu et al [21]

Ethiopia

Cross-sectional

2020

2018

Pregnant

347

Self –Report

Not reported

Yes

42

Zacharius et al [63]

Tanzania

Cross-sectional

2019

2017

Pregnant and breastfeeding

305

Pill count

30

Yes

43

Zoungrana-Yameogo et al. [64]

Burkina-Faso

Cross-sectional

2022

2019-2020

Pregnant and breastfeeding

112

Self -Report

30

Yes